The Filing Desk

Organogenesis vs RxSight

Organogenesis ORGO · RxSight RXST · Health Care Supplies

Organogenesis reported revenue of $564 million in fiscal 2025, 4.2 times RxSight's $134 million in fiscal 2025. Organogenesis' revenue grew 17.0% in its latest year, and RxSight's fell 3.9%. Organogenesis had an operating margin of 7.9%, against -35.8% at RxSight. Free cash flow was −$24 million at Organogenesis and −$19 million at RxSight.

Side by side

OrganogenesisRxSight
Latest fiscal yearFY2025, Dec 31, 2025FY2025, Dec 31, 2025
Revenue$564M$134M
Revenue growth17.0%−3.9%
Revenue growth a year, last 5 years10.8%55.7%
Gross margin—76.6%
Operating margin7.9%−35.8%
Net margin6.6%−29.0%
Free cash flow−$24M−$19M
Free cash flow margin−4.3%−14.4%
Return on capital—−82.9%
Net debt to EBITDA——
Dividends and buybacks$0M$0M
Change in diluted share count−1.1%5.1%
Last close$0.79$4.61
P/E at the last close——
Insider trades, last 12 monthsbought $40,100, sold $2.6 millionsold $103,745
Piotroski F-score—3 of 9
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.

Ten years

Revenue
US$ billions, fiscal years
OrganogenesisRxSight
Operating margin
Percent of revenue
OrganogenesisRxSight
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
OrganogenesisRxSight

Start a new comparison

Source: the companies' Form 10-K filings, from SEC EDGAR, and the last close. For information only, not investment advice: the figures describe results, not which company is the better investment. The Filing Desk is not affiliated with either company. Full figures on the Organogenesis and RxSight pages.